These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21656735)

  • 1. Lung cancer a hot topic at AACR meeting: studies offer promise in detection, prevention, and personalized medicine.
    Printz C
    Cancer; 2011 Jun; 117(12):2583-5. PubMed ID: 21656735
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized medicine for non-small-cell lung cancer.
    Mok TS; Zhou Q; Leung L; Loong HH
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1601-11. PubMed ID: 20942631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection and chemoprevention of lung cancer.
    Shaipanich T; McWilliams A; Lam S
    Respirology; 2006 Jul; 11(4):366-72. PubMed ID: 16771906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecularly targeted approaches to the chemoprevention of lung cancer.
    Khuri FR; Cohen V
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4249s-4253s. PubMed ID: 15217968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung carcinoma in the era of personalized medicine: the role of cytology.
    Zakowski MF; Bibbo M
    Acta Cytol; 2012; 56(6):587-9. PubMed ID: 23207435
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
    Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
    Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F
    Lung Cancer; 2010 Jun; 68(3):319-31. PubMed ID: 20036027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular origins of lung cancer: prospects for personalized prevention and therapy.
    Haura EB; Camidge DR; Reckamp K; Chiappori A; Johnson F; Herbst R; Wong K; Carbone D
    J Thorac Oncol; 2010 Jun; 5(6 Suppl 3):S207-13. PubMed ID: 20502275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and early detection].
    Andreas S; Gamarra F; Herth F; Hoffmann H; Nowak D; Riha S; Thomasius R; Wormanns D
    Onkologie; 2011; 34 Suppl 4():2-10. PubMed ID: 21677467
    [No Abstract]   [Full Text] [Related]  

  • 10. Lung cancer chemoprevention: an integrated approach.
    Lippman SM; Spitz MR
    J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small step towards personalized medicine for non-small cell lung cancer.
    Mok T; Wu YL; Zhang L
    Discov Med; 2009 Dec; 8(43):227-31. PubMed ID: 20040275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer: chemoprevention and intermediate effect markers.
    Tockman MS
    IARC Sci Publ; 2001; 154():257-70. PubMed ID: 11220665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoprevention of lung cancer. A review about previous studies, results and future developments].
    Heckmayr M
    Pneumologie; 2004 Jun; 58(6):408-15. PubMed ID: 15216434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic growth regulation of cell lines derived from human lung adenocarcinomas of Clara cell and aveolar type II cell lineage: Implications for chemoprevention.
    Adissu HA; Schuller HM
    Int J Oncol; 2004 Jun; 24(6):1467-72. PubMed ID: 15138589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemoprevention of bronchogenic carcinoma].
    Votruba J; St'astný B
    Cas Lek Cesk; 2000 Nov; 139(22):702-4. PubMed ID: 11191751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
    J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention in lung carcinogenesis--an overview.
    van Zandwijk N
    Eur J Cancer; 2005 Sep; 41(13):1990-2002. PubMed ID: 16112567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
    Crawford J
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.
    García B; Neninger E; de la Torre A; Leonard I; Martínez R; Viada C; González G; Mazorra Z; Lage A; Crombet T
    Clin Cancer Res; 2008 Feb; 14(3):840-6. PubMed ID: 18245547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer prevention and screening.
    Moyer V
    Oncology (Williston Park); 2014 May; 28(5):449-50. PubMed ID: 25004663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.